US Bill Seeks To Eliminate Biosimilar Interchangeability Trial Burden

‘Biosimilar Red Tape Elimination Act’ Would Remove Need For Switching Studies

Scissors cutting red tape
The bill is aimed at eliminating “red tape and unnecessary studies” • Source: Shutterstock

More from Policy & Regulation

More from Generics Bulletin